The deal expands Roche's pipeline in oncology and potentially other therapeutic areas.
Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion
The deal expands Roche's pipeline in oncology and potentially other therapeutic areas.
Author: WSJ
Read Original Article